Voyageur Pharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Public
- Stock Symbol
-
VM
- Investments
-
3
- Share Price
-
$0.09
- (As of Friday Closing)
Voyageur Pharmaceuticals General Information
Description
Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring and developing raw materials for pharmaceutical products.
Contact Information
Website
www.voyageurpharmaceuticals.caCorporate Office
- Dome Tower 800
- 333 7 Avenue SouthWest
- Calgary, Alberta T2P 2Z1
- Canada
Corporate Office
- Dome Tower 800
- 333 7 Avenue SouthWest
- Calgary, Alberta T2P 2Z1
- Canada
Voyageur Pharmaceuticals Timeline
Voyageur Pharmaceuticals Stock Performance
As of 17-Jan-2025, Voyageur Pharmaceuticals’s stock price is $0.09. Its current market cap is $13.9M with 148M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.09 | $0.10 | $0.03 - $0.15 | $13.9M | 148M | 247K |
Voyageur Pharmaceuticals Financials Summary
As of 31-Aug-2024, Voyageur Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Aug-2024 | FY 2023 30-Nov-2023 | FY 2022 30-Nov-2022 | FY 2021 30-Nov-2021 |
|---|---|---|---|---|
| EV | 5,189 | 3,923 | 5,731 | 6,069 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,124) | (1,030) | (1,346) | (1,626) |
| Net Income | (1,125) | (1,035) | (1,353) | (1,635) |
| Total Assets | 1,730 | 1,592 | 1,542 | 2,014 |
| Total Debt | 30 | 29 | 19 | 33 |
Voyageur Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Voyageur Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Voyageur Pharmaceuticals Investments & Acquisitions (3)
Voyageur Pharmaceuticals’s most recent deal was a Joint Venture with ImagingX Pharmaceuticals. The deal was made on 09-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ImagingX Pharmaceuticals | 09-Jan-2019 | Joint Venture | Specialty Chemicals | ||
| Voyageur Minerals/Innovation Metals (Joint venture) | 20-Mar-2018 | Joint Venture | Other Metals, Minerals and Mining | ||
| Golden Sun Capital | 02-Mar-2017 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Voyageur Pharmaceuticals FAQs
-
When was Voyageur Pharmaceuticals founded?
Voyageur Pharmaceuticals was founded in 2017.
-
Where is Voyageur Pharmaceuticals headquartered?
Voyageur Pharmaceuticals is headquartered in Calgary, Canada.
-
What industry is Voyageur Pharmaceuticals in?
Voyageur Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Voyageur Pharmaceuticals a private or public company?
Voyageur Pharmaceuticals is a Public company.
-
What is Voyageur Pharmaceuticals’s stock symbol?
The ticker symbol for Voyageur Pharmaceuticals is VM.
-
What is the current stock price of Voyageur Pharmaceuticals?
As of 17-Jan-2025 the stock price of Voyageur Pharmaceuticals is $0.09.
-
What is the current market cap of Voyageur Pharmaceuticals?
The current market capitalization of Voyageur Pharmaceuticals is $13.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
